NSE:SPARC (India)
Â
Ordinary Shares
₹
239.37
+0.050 (+0.02%)
Jul 3
Business Description
Sun Pharma Advanced Research Co Ltd
ISIN : INE232I01014
Share Class Description:
NSE:SPARC: Ordinary SharesTotal Employee Number:
316Compare
Compare
Traded in other countries / regions
532872.India Index Membership
NIFTY 500 IPO Date
2007-07-18Description
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in other countries.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.42 | |||||
Debt-to-EBITDA | 0.35 | |||||
Interest Coverage | 46.54 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 9.15 | |||||
Beneish M-Score | 22.25 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 90.4 | |||||
3-Year FCF Growth Rate | -39.7 | |||||
3-Year Book Growth Rate | 37.7 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 72.96 | |||||
9-Day RSI | 66.5 | |||||
14-Day RSI | 65.11 | |||||
3-1 Month Momentum % | 68.06 | |||||
6-1 Month Momentum % | 53.63 | |||||
12-1 Month Momentum % | 30.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.47 | |||||
Quick Ratio | 2.47 | |||||
Days Sales Outstanding | 1.96 | |||||
Days Payable | 806.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -3.06 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 97.54 | |||||
Operating Margin % | 84.54 | |||||
Net Margin % | 82.65 | |||||
EBITDA Margin % | 85 | |||||
FCF Margin % | -13.97 | |||||
OCF Margin % | -12.71 | |||||
ROE % | 599.51 | |||||
ROA % | 164.72 | |||||
ROIC % | 143.36 | |||||
3-Year ROIIC % | 108.07 | |||||
ROC (Joel Greenblatt) % | 245.48 | |||||
ROCE % | 393.94 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 4.82 | |||||
Forward PE Ratio | 3.82 | |||||
PE Ratio without NRI | 4.8 | |||||
PS Ratio | 3.99 | |||||
PB Ratio | 5.59 | |||||
Price-to-Tangible-Book | 6.12 | |||||
EV-to-EBIT | 5.23 | |||||
EV-to-EBITDA | 5.2 | |||||
EV-to-Revenue | 4.42 | |||||
EV-to-FCF | -29.88 | |||||
Price-to-GF-Value | 0.05 | |||||
Price-to-Median-PS-Value | 0.09 | |||||
Price-to-Graham-Number | 1.16 | |||||
| Price-to-Net-Current-Asset-Value | 7.53 | |||||
Earnings Yield (Greenblatt) % | 19.09 | |||||
FCF Yield % | -3.38 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sun Pharma Advanced Research Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 18,791.7 | ||
| EPS (TTM) (₹) | 47.85 | ||
| Beta | 1.4255 | ||
| 3-Year Sharpe Ratio | 0.23 | ||
| 3-Year Sortino Ratio | 0.39 | ||
| Volatility % | 58.55 | ||
| 14-Day RSI | 65.11 | ||
| 14-Day ATR (₹) | 10.679759 | ||
| 20-Day SMA (₹) | 228.2985 | ||
| 12-1 Month Momentum % | 30.89 | ||
| 52-Week Range (₹) | 108 - 253.17 | ||
| Shares Outstanding (Mil) | 324.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sun Pharma Advanced Research Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sun Pharma Advanced Research Co Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sun Pharma Advanced Research Co Ltd Frequently Asked Questions
What is Sun Pharma Advanced Research Co Ltd(NSE:SPARC)'s stock price today?
The current price of NSE:SPARC is ₹239.37. The 52 week high of NSE:SPARC is ₹253.17 and 52 week low is ₹108.00.
When is next earnings date of Sun Pharma Advanced Research Co Ltd(NSE:SPARC)?
The next earnings date of Sun Pharma Advanced Research Co Ltd(NSE:SPARC) is .
Does Sun Pharma Advanced Research Co Ltd(NSE:SPARC) pay dividends? If so, how much?
Sun Pharma Advanced Research Co Ltd(NSE:SPARC) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| OneThree Biotech Joins Forces with SPARC to Characterize a Key Oncologic Pathway | 2021-06-08 |
Articles on Sun Pharma Advanced Research Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers